The Recall Desk

Manufacturer

Novartis Pharmaceuticals Corp.

26 recalls in our database name Novartis Pharmaceuticals Corp. as the manufacturing or recalling firm.

What the numbers show

Total
26
Critical
1
Severe
5
Most recent
2023-09-27

Of the 26 recalls from Novartis Pharmaceuticals Corp. we have scored against our rubric, 1 (4%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 5 (19%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

26–26 of 26

  • ModerateFDA (Drugs)·D-333-2014·2013-12-18

    Novartis Recalls Physician Sample Blood Pressure Medications Due to Chemical Contamination

    Novartis is recalling physician sample bottles of several blood pressure medications due to contamination with a photocuring agent found in packaging inks.

    Product
    Exforge (amlodipine and valsartan Tablets) 10/160 mg, Rx only, 7 tablets per bottle, Physician Sample - Not For Sale. Manufactured by: Novartis Pharma Stein AG Stein, Switzerland. Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC # 0078-9489-07
    Category
    Drug
    Distribution
    Distributed nationwide